CRISPR Therapeutics AG

NASDAQ: CRSP · Real-Time Price · USD
41.92
3.35 (8.69%)
At close: Jun 06, 2025, 3:59 PM
41.85
-0.17%
After-hours: Jun 06, 2025, 05:59 PM EDT

CRISPR Therapeutics Statistics

Share Statistics

CRISPR Therapeutics has 86.36M shares outstanding. The number of shares has increased by 1.01% in one year.

86.36M
1.01%
0.49%
76.5%
n/a
1,023
0.05%

Short Selling Information

The latest short interest is 21.07M, so 24.39% of the outstanding shares have been sold short.

21.07M
24.39%
27.73%
9.88

Valuation Ratios

The PE ratio is -9.07 and the forward PE ratio is -8.65. CRISPR Therapeutics's PEG ratio is -0.07.

-9.07
-8.65
94.87
1.5
1.72
-22.95
-0.07
Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for CRISPR Therapeutics.

n/a
n/a
n/a
n/a

Financial Position

The company has a current ratio of 22.07, with a Debt / Equity ratio of 0.12.

22.07
22.07
0.12
-0.5
-1.55
0

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

n/a
n/a
n/a
$89,058.52
$-931,938.93
393
0.02
n/a

Taxes

3.59M
-0.99%

Stock Price Statistics

The stock price has increased by -27.56% in the last 52 weeks. The beta is 1.74, so CRISPR Therapeutics's price volatility has been higher than the market average.

1.74
-27.56%
36.86
43.36
65.17
2,057,009

Income Statement

In the last 12 months, CRISPR Therapeutics had revenue of 35M and earned -366.25M in profits. Earnings per share was -4.34.

35M
37.31M
-466.57M
-366.25M
-447.31M
-466.57M
-4.34
Full Income Statement

Balance Sheet

The company has 298.26M in cash and 223.69M in debt, giving a net cash position of 74.56M.

298.26M
223.69M
74.56M
-1.37B
2.17B
1.75B
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -142.77M and capital expenditures -1.9M, giving a free cash flow of -144.68M.

-142.77M
-1.9M
-144.68M
-1.71
Full Cash Flow Statement

Margins

Gross margin is 106.61%, with operating and profit margins of -1333.05% and -1046.43%.

106.61%
-1333.05%
-1036.19%
-1046.43%
-1278.02%
-1333.05%
-413.36%

Dividends & Yields

CRSP does not appear to pay any dividends at this time.

n/a
n/a
n/a
n/a
n/a
n/a
Dividend Details

Analyst Forecast

The average price target for CRSP is $81.5, which is 94.4% higher than the current price. The consensus rating is "Buy".

$81.5
94.4%
Buy
16
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

n/a
n/a
n/a
n/a

Scores

5.02
1